Vision and Mission
Team and Partners
For whom we work
Version imprimable de cet article Printable version

Jean-Claude Piffaretti

founder and director of Interlifescience

J.-C. Piffaretti obtained in 1974 a Ph.D. degree in biological science from the Geneva University, Switzerland. Since the beginning of his professional career, he has been overlapping general and medical microbiology. From 1981 to 2006, he was deputy director of the Cantonal Institute of Microbiology of the Canton Ticino, Switzerland, where he supervised the clinical laboratory (he has the Swiss FAMH certificate in laboratory medicine, medical microbiology). During this period, he headed his own research group financed mostly by the Swiss National Foundation and published about 100 scientific articles, the majority of them in international peer reviewed journals. He also received several mandates from the Swiss Federal Office of Public Health. He also served as an expert to the Swiss Accreditation Service for the medical microbiology laboratories.

J.-C. Piffaretti has been organising numerous courses, workshops, meetings and congresses in microbiology. In 2006, he chaired the organising committee of the 2nd FEMS congress of European microbiologists, in Madrid. In September 2010 he was elected vice-president of FEMS (Federation of European Microbiological Societies) and president in 2013. In December 2016, he was elected fellow of EAM (European Academy of Microbiology).

In 1993, J.-C. Piffaretti has been appointed associate professor at the Faculty of Medicine of the University of Geneva, where he taught microbiology to the pharmacy and biology students until 2011. From 2009 to 2013 he also taught microbiology to the medicine students of the University of Fribourg.

Selected appointments

Member of the Swiss Expert Committee for Biosafety

President of the Swiss Society for Microbiology

President of the steering committee of the National Research Programme NRP 49 (Antibiotic resistance)

Member of the scientific committee of the FEMS Lwoff Award

Member of the FEMS Executive Board (Federation of the European Microbiology Societies)

Member of the coordination group of the Canton Ticino for the pandemic influenza

Member of the scientific evaluation committees of the Institut Pasteur, Paris, and INSERM (France)

Co-founder and member of the board of the Foundation of the Institute of Research in Biomedicine (IRB), Bellinzona, Switzerland

Member of the Swiss Gene Therapy Working Group

Member of the scientific committee of the Pfizer Award Foundation

Receiving editor of Infection, Genetics and Evolution

Permanent expert of the KomABC (Federal Commission for NBC-Protection). Since 2008: full member and member of the executive committee

President of Pharmapetides (teaching and research centre in biopharmaceutical sciences of the Geneva and Lyon Universities)

Member of the National Reference Centres Committee of InVS, France (Institut de Veille Sanitaire, National Institute of Public Health Surveillance). President since 2012.

President of the Swiss Federal Committee "Influenza Work Group"

President of the Swiss Federal Committee for pandemics’ preparedness (EKP)

Vice-president (2010-2013) and president (2013-2016) of FEMS (Federation of the European Microbiology Societies)

Fellow of the European Academy of Microbiology (EAM)

The Association Round Table Antibiotics has been founded in Bern on June 24, 2019.
29 October 2019

The Round Table Antibiotics is a Swiss non-profit interdisciplinary Association gathering experts from medicine, research and economics of almost all Swiss universities, as well as committed personalities from industry or elsewhere.

The aim of the Association Round Table Antibiotics is to drive Switzerland’s contribution to innovation, research, and development of measures against antimicrobial resistance, particularly by promoting the market introduction of new active substances, which should be available to all countries worldwide.

Additional information:

Appeal to the Swiss Federal Council for an innovative financing model for the research on new antimicrobials
26 November 2017

On 9 November 2017, the Round Table on Antibiotics launched an appeal to the Federal Council to establish a dialogue in Switzerland between all partners involved in antibiotic research (academic research, economics, small and medium-sized enterprises, pharmaceutical industry, etc.). This dialogue should aim at defining, developing and implementing an innovative financing model for the research, development and marketing of new antibiotics that are financially accessible to all.

The text of the call of November 9, 2017 can be seen under "Publications"

The World Antibiotic Awareness Week will be held on 13-19 November 2017. Switzerland will participate.
8 November 2017

With the purpose of raising awareness of antibiotic resistance and improving the prudent use of antimicrobials, WHO (World Health Organisation) is organising a World Antibiotic Awareness Week since 2015. This year the event will be held from November 13 to 19. For the first time, Switzerland will actively participate to this week. Indeed, the crisis of bacterial resistance to antibiotics is such that an increasing number of infections is becoming difficult to treat, or even impossible. WHO is deeply concerned with this issue and is stimulating its state members to organise campaigns at the national level. Switzerland has already reacted to the antibiotic resistance issue by promoting a National Research Programme of 20 millions CHF(NRP 72) as well as a national Strategy on antibiotic resistance (StAR).

Additional information: StAR NRP72

interlifescience   Via San Gottardo 92, 6900 Massagno, Switzerland - T : +41 91 960 05 55 - F : +41 91 960 05 56
ByteCode - informatique libre